We are live on ! Find out more
NVO icon

Novo Nordisk

549 hedge funds and large institutions have $11.7B invested in Novo Nordisk in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 190 increasing their positions, 194 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

577% more call options, than puts

Call options by funds: $34.8M | Put options by funds: $5.14M

26% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 35

19% more funds holding in top 10

Funds holding in top 10: 32 → 38 (+6)

4% more funds holding

Funds holding: 526 → 549 (+23)

0.05% less ownership

Funds ownership: 8.92% → 8.87% (-0.05%)

2% less repeat investments, than reductions

Existing positions increased: 190 | Existing positions reduced: 194

13% less capital inflows, than outflows

Capital inflows: $475M | Capital outflows: $544M

Holders
549
Holders Change
+23
Holders Change %
+4.37%
% of All Funds
14.36%
Holding in Top 10
38
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+18.75%
% of All Funds
0.99%
New
44
Increased
190
Reduced
194
Closed
35
Calls
$34.8​M
Puts
$5.14​M
Net Calls
+$29.6​M
Net Calls Change
+$44.2​M

NVO Hedge Fund Activity: Q4 2015 in Review

549 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2015, worth a combined $11.7B — up 6.5% from $11B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NVO positions and 35 closed out — a net gain of 9 holders — while 190 added to existing stakes and 194 trimmed.

The largest buyer was WCM Investment Management, adding an estimated $77.3M. The largest seller was Jennison Associates, cutting an estimated $178M.

  • 549 institutional investors held Novo Nordisk (NVO) as of Q4 2015, up from 526 in Q3 2015.
  • Funds reported $11.7B of Novo Nordisk stock for Q4 2015, up 6.5% quarter-over-quarter.
  • 44 funds opened new Novo Nordisk positions in Q4 2015 and 35 closed out, a net change of +9 holders.
  • The largest Novo Nordisk buyer in Q4 2015 was WCM Investment Management, an estimated $77.3M added.
  • The largest Novo Nordisk seller in Q4 2015 was Jennison Associates, an estimated $178M sold.

Based on aggregated 13F filings for Q4 2015.